Sentences with phrase «diabetes researchers used»

In a study that perhaps more serves as proof that NAD + deficiency plays a role in diabetes researchers used high

Not exact matches

Researchers found that 100 grams per day significantly reduced blood sugar levels in the subjects, and concluded that they could be used as a dietary supplement in the management of type 1 and type 2 diabetes.

Researchers at Google are hopeful that one day this technology might be used to help diabetes patients better control their disease.

To investigate, researchers led by Roberto Pisoni, MD (Medical University of South Carolina) analyzed information on 56 patients with diabetes and CKD who had undergone screening for obstructive sleep apnea through the use of a questionnaire.

A pilot study led by researchers at Joslin Diabetes Center has revealed that it is possible to use magnetic resonance imaging (MRI) to «see» the inflammation in the pancreas that leads to type 1 dDiabetes Center has revealed that it is possible to use magnetic resonance imaging (MRI) to «see» the inflammation in the pancreas that leads to type 1 diabetesdiabetes.

The researchers constructed a signature for type 2 diabetes based on 50 genes, then used publically available expression datasets to screen 3,852 compounds for drugs that potentially reverse disease.

The researchers used these data to see how factors like income, race and ethnicity, sex and location affected rates of diabetes diagnosis and foregone medical care due to cost.

The researchers used the dead guide RNAs to turn on the Pdx gene in the mice's livers, which caused the liver cells to produce insulin, reversing the mice's diabetes.

The association between the two conditions remained significant even when researchers adjusted for other risk factors, including age, gender, race, body mass index, physical activity, history of alcohol use and smoking, and history of other conditions like myocardial infarction, stroke and diabetes mellitus.

Experiments with a compound called TNP [N2 -(m - Trifluorobenzyl), N6 -(p - nitrobenzyl) purine], which researchers often use to study obesity and diabetes, show that in mice the therapy can promote the formation of new bone.

The researchers used two different mouse models of diabetes to study the effects of the diet.

Researchers have used cells that develop into sperm to create a type of pancreatic cell (blue) that secrete insulin (red), which may one day cure type 1 diabetes in men.

By use of a shared decision - making recruitment strategy targeting the entire at - risk population within an integrated community healthcare system, the researchers screened 1,808 adults meeting inclusion criteria (age 25 - 64, with type 2 diabetes and a BMI 30 - 45 kg / m2).

For the future, the researchers also envisage the use of Glucolight in other fields, such as diabetes.

Researchers conducted a nationwide, population - based long - term observational cohort study using the Swedish Multi-Generation Register to monitor the risk of nonceliac autoimmune disease, which includes Crohn's disease, type 1 diabetes mellitus, hypothyroidism, hyperthyroidism, psoriasis, rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus and ulcerative colitis.

After adjusting for numerous possible confounding factors, including body mass index and alcohol use, the researchers found that women in the highest quartile of GGT had nearly twice the risk of subsequent gestational diabetes than those in the lowest quartile.

Roughly 250 published studies about diabetes were conducted using these tainted mice, continues Professor Creemers: «In many of them, researchers were looking to see if a given gene played a role in insulin production.

Researchers from Boston University School of Medicine (BUSM) used these same subjects, but added additional AD risk information (smoking status, diabetes status, education level) to their statistical modeling to increase the power of the study.

For this study, the researchers used data from a population of patients with both diabetes and chronic kidney disease (stage 3 and 4) enrolled in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 1diabetes and chronic kidney disease (stage 3 and 4) enrolled in follow up studies conducted by Dr. Krolewski and his team at the Joslin Diabetes Center and followed for four to 1Diabetes Center and followed for four to 15 years.

A new study by researchers from the University of Chicago Medicine, based on a 6 - month clinical trial, finds that use of a CGM is cost - effective for adult patients with type 1 diabetes when compared to daily use of test strips.

After adjusting the data for age, sex, race, education, smoking, alcohol use, blood pressure, diabetes, high blood pressure medication, cholesterol levels, statin use and body mass index, the researchers found that those people who met both the recommended activity levels and had vitamin D levels above 20 nanograms per milliliter experienced about a 23 percent less chance of having an adverse cardiovascular event than those people with poor physical activity who were deficient for vitamin D. On the other hand, people who had adequate exercise but were vitamin D deficient didn't have a reduced risk of an adverse event.

To illustrate the power of the innovative technique, the TSRI researchers used it to identify a compound that shows promise for treating obesity - linked diabetes.

Using a computational model, the researchers estimated that replacing approximately 5 grams of animal protein with plant protein daily would reduce the risk of diabetes by 18 per cent.

According to Herlyn, the researchers used the diabetes drug phenformin in their studies, but they are now working with colleagues to develop a clinical trial using a drug with less toxic side effects.

What the researchers found using this technique could have significant impact on both the understanding and treatment of obesity, diabetes and cardiovascular disease.

The researchers say the technique, which uses cellular reprogramming, could be a new way to combat obesity and type II diabetes.

Researchers hope to use transplanted fetal tissue in treatments for infant diabetes, Parkinson's disease, and some severe immune deficiencies.

Researchers at the University of California, Riverside have tested a genetically - modified (GM) soybean oil used in restaurants and found that while it induces less obesity and insulin resistance than conventional soybean oil, its effects on diabetes and fatty liver are similar to those of conventional soybean oil.

Before the cells can be used to treat type 1 diabetes, researchers need to find a way to protect them from immunologic rejection.

As reported today in Science Advances, the researchers were able to use the method to identify specific metabolic signatures that could arise in diabetes, cancer, cardiovascular and neurodegenerative diseases.

In an elegant proof - of - principle approach, the researchers used synthetic molecules to decrease the physical distance between the ER and mitochondria in cells and in liver tissue and found that this intervention impaired mitochondrial function and made mice more sensitive to high fat diet - induced insulin resistance and diabetes.

Since 2003, Kevin Hall, PhD — a physicist turned metabolism researcher at the National Institute of Diabetes and Digestive and Kidney Diseases — has been using data from dozens of controlled feeding studies conducted over decades of nutrition research to build mathematical models of how different nutrients affect human metabolism and body weight.

Using data from a United Kingdom database known as The Health Improvement Network (THIN), researchers extracted health records of more than 12,000 patients ages 55 and older who had Type 2 diabetes and heart failure but no prior history of heart attack, stroke, peripheral artery disease or atrial fibrillation.

Widely used treatments for type 2 diabetes have different effects on the hearts of men and women, even as the drugs control blood sugar equally well in both sexes, according to researchers at the School of Medicine.

A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz Medical Campus and the University of Florida in Gainesville.

The Portal is designed to help dramatically expand the number of researchers who can use human genetic data to study type 2 diabetes.

Using deCODE's proprietary analysis tool for complex traits, the deCODE Clinical Genome Miner ™, the researchers were able to correlate a wide range of clinical, behavioral, and genotypic data, and gained important new insights into the heritability of different aspects of obesity, as well as into the complex interplay between obesity and diabetes, stroke, heart disease, and hyperlipidemia.

Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes.

Stem cell researchers hope to discover how organisms develop from a single cell and how healthy cells might be used to replace damaged cells that cause such diseases as diabetes, Parkinson's and Lou Gehrig's disease.

6/5/2008 Moores UCSD Cancer Center Study Links Vitamin D, Type 1 Diabetes Global View Supports Concept of Using Vitamin D in Reducing Disease Risks Sun exposure and vitamin D levels may play a strong role in risk of type 1 diabetes in children, according to new findings by researchers at the Moores Cancer Center at Unive...Diabetes Global View Supports Concept of Using Vitamin D in Reducing Disease Risks Sun exposure and vitamin D levels may play a strong role in risk of type 1 diabetes in children, according to new findings by researchers at the Moores Cancer Center at Unive...diabetes in children, according to new findings by researchers at the Moores Cancer Center at Unive... More...

UC Davis researchers used eyes from mice with diabetes to look at the role of electric fields in wound healing.

The researchers used two national databases, one extending back to 1994, to assess trends in diabetes treatment.

The researchers first discovered ascarosides as a signaling molecule in C. elegans, a nematode used as a model organism to study cell, developmental and nervous system biology, as well as human aging and diabetes.

It's impossible to know every possible medical use of stem cells because scientists haven't been able to conduct extensive research with them, but researchers claim that they may be the key to treating a host of diseases and conditions, including Parkinson's disease, diabetes, heart disease, multiple sclerosis, baldness and spinal cord injuries.

Now researchers in the U.S. and Canada want to hold the first anti-aging clinical trial to see if they can replicate the same effect in humans using a diabetes drug called metformin.

In a new study, researchers have successfully reversed diabetes in mice using stem cells, thereby paving the way for a...

The researchers followed up to identify markers of aging in these cells, using several mouse models — one with impaired glucose tolerance (a contributor to type 2 diabetes progression) and another that shows markers of rapid aging.

Using the drug aldesleukin (recombinant interleukin - 2), presently administered in high doses to combat kidney tumours and skin cancers, researchers at the University of Cambridge hope to tailor its dosage to modulate the immune response in type 1 diabetes.

Our NMR - based metabolomics platform has been used by academic researchers to improve risk prediction and for biomarker discovery of cardiovascular diseases, type 2 diabetes and other disease targets.

Using the same principle, the researchers are hopeful of designing nanoparticles with the ability to cross other barriers, which could be used to treat other conditions, such as diabetes, arthritis and high cholesterol.